31.10.2014 Views

Dr. Lorenzo Gianni - Oncologia Rimini

Dr. Lorenzo Gianni - Oncologia Rimini

Dr. Lorenzo Gianni - Oncologia Rimini

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Bevacizumab safety in patients with<br />

central nervous system metastases.<br />

Pts Occult SNC+ BEV No BEV<br />

Dataset A 8,443 187 91 96<br />

Dataset B 4,382 321 321<br />

Dataset C<br />

131 (Mets<br />

SNC trattate)<br />

3 (3.3%, G4) 1 (1,0%, G5)<br />

3 (0.9%, 2 G1 e 1 G3)<br />

1 (0,8%, G2)<br />

In questa popolazione selezionata, pz con metastasi SNC rischio simimle di<br />

emorragia SNC indipendentemente da BV.<br />

Consequentemente, tali pz con metastasi SNC da ca mammario<br />

avanzato/metastatico, NSCLC, renale e colorettale non dovrebbero in assoluto essere<br />

esclusi dalla terapia con BV o dai trials clinici<br />

Besse B et al. Clin Cancer Res. 2010; 16(1):269-78

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!